This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Brand Names
- FOCLIVIA
- Generic Name
- Influenza A virus A/Vietnam/1194/2004 (H5N1) antigen (formaldehyde inactivated)
- DrugBank Accession Number
- DB16646
- Background
Not Available
- Type
- Biotech
- Groups
- Approved
- Biologic Classification
- Vaccines
Inactivated - Synonyms
- Haemagglutinin-strain A (H5N1)
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- International/Other Brands
- FOCLIVIA (Seqirus UK Limited)
- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Adjupanrix 3.75 μg Intramuscular Glaxosmithkline Biologicals S.A. 2016-09-07 Not applicable EU 
Foclivia Injection, suspension 7.5 μg/0.5ml Intramuscular Seqirus S.R.L. 2016-09-08 Not applicable EU Foclivia Injection, suspension 7.5 μg/0.5ml Intramuscular Seqirus S.R.L. 2016-09-08 Not applicable EU Foclivia Suspension 7.5 mcg / 0.5 mL Intramuscular Seqirus S.R.L. Not applicable Not applicable Canada 
Foclivia Injection, suspension 7.5 μg/0.5ml Intramuscular Seqirus S.R.L. 2020-12-16 Not applicable EU - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Arepanrix H5n1 Influenza A virus A/Vietnam/1194/2004 (H5N1) antigen (formaldehyde inactivated) (3.75 mcg / 0.5 mL) + DL-alpha-Tocopherol (11.86 mg / 0.5 mL) + Polysorbate 80 (4.86 mg / 0.5 mL) + Squalene (10.69 mg / 0.5 mL) Emulsion Intramuscular ID Biomedical Corporation of Quebec Not applicable Not applicable Canada
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- Not Available
- CAS number
- Not Available
References
- General References
- Not Available
- External Links
- Not Available
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Injection, emulsion Intramuscular 3.75 mcg Emulsion Intramuscular Injection, suspension Intramuscular 7.5 μg/0.5ml Suspension Intramuscular 7.5 mcg / 0.5 mL Suspension Intramuscular 7.5 mcg / vial Injection, suspension Intramuscular 7.5 micrograms/0.5ml Injection, suspension Intramuscular 7.5 mcg/0.5ml - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at March 20, 2021 18:08 / Updated at March 21, 2021 02:08